NASDAQ

Dyne Therapeutics, Inc. (DYN)

♥ 566 Thanks from members

Live price chart, market sentiment, and community perspectives for Dyne Therapeutics, Inc. (NASDAQ: DYN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: StablixFounder: Dyne Therapeutics TeamLeadership: Joshua Brumm (CEO)Holder: RA Capital ManagementHolder: Entities affiliated with FMRHolder: VanguardDYNE-101DYNE-251FORCE Platform#DYN#Dyne Therapeutics#Muscle Diseases#Biotech#NASDAQ